Insmed to Host Second-Quarter 2024 Financial Results Conference Call on Thursday, August 8, 2024
Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company focused on rare diseases, has announced its upcoming second-quarter 2024 financial results conference call. The call is scheduled for Thursday, August 8, 2024, at 8:00 a.m. ET. Investors and interested parties can participate by dialing (888) 210-2654 (U.S.) or (646) 960-0278 (international) with access code 7862189. The call will also be webcast live on the company's website.
A replay of the conference call will be available until September 7, 2024, and a webcast recording will be archived for 90 days on Insmed's website. This event provides an opportunity for stakeholders to gain insights into Insmed's financial performance and receive updates on the company's business activities.
Insmed Incorporated (Nasdaq: INSM), un'azienda biofarmaceutica globale focalizzata sulle malattie rare, ha annunciato la prossima conferenza telefonica sui risultati finanziari del secondo trimestre 2024. La chiamata è programmata per giovedì 8 agosto 2024, alle 8:00 ET. Gli investitori e le parti interessate possono partecipare componendo il numero (888) 210-2654 (USA) o (646) 960-0278 (internazionale) utilizzando il codice di accesso 7862189. La chiamata sarà anche trasmessa in diretta sul sito web dell'azienda.
Una registrazione della conferenza sarà disponibile fino al 7 settembre 2024, e una registrazione della trasmissione sarà archiviata per 90 giorni sul sito di Insmed. Questo evento offre un'opportunità agli stakeholder per ottenere informazioni sulle performance finanziarie di Insmed e ricevere aggiornamenti sulle attività aziendali.
Insmed Incorporated (Nasdaq: INSM), una empresa biofarmacéutica global enfocada en enfermedades raras, ha anunciado su próxima llamada de conferencia sobre los resultados financieros del segundo trimestre de 2024. La llamada está programada para jueves 8 de agosto de 2024, a las 8:00 a.m. ET. Los inversores y partes interesadas pueden participar marcando (888) 210-2654 (EE. UU.) o (646) 960-0278 (internacional) con el código de acceso 7862189. La llamada también se transmitirá en vivo en el sitio web de la empresa.
Una repetición de la conferencia estará disponible hasta el 7 de septiembre de 2024, y una grabación de la transmisión estará archivada durante 90 días en el sitio web de Insmed. Este evento brinda una oportunidad para que las partes interesadas obtengan información sobre el rendimiento financiero de Insmed y reciban actualizaciones sobre las actividades comerciales de la empresa.
인스메드 주식회사(나스닥: INSM)는 희귀 질환에 초점을 맞춘 글로벌 생명공학 회사로서, 2024년 2분기 재무 결과 발표를 위한 컨퍼런스 콜을 발표했습니다. 이 콜은 2024년 8월 8일 목요일 오전 8시 ET에 예정되어 있습니다. 투자자 및 이해관계자는 (888) 210-2654 (미국) 또는 (646) 960-0278 (국제)로 전화하여 접속 코드 7862189로 참여할 수 있습니다. 이 콜은 회사 웹사이트에서 실시간으로 생중계됩니다.
컨퍼런스 콜의 다시보기는 2024년 9월 7일까지 이용 가능하며, 인스메드 웹사이트에서 90일간 아카이브된 웹캐스트 레코딩이 제공됩니다. 이 이벤트는 이해관계자들에게 인스메드의 재무 성과에 대한 통찰력을 제공하고 회사의 비즈니스 활동에 대한 업데이트를 받을 수 있는 기회를 제공합니다.
Insmed Incorporated (Nasdaq: INSM), une entreprise biopharmaceutique mondiale axée sur les maladies rares, a annoncé sa prochaine conférence téléphonique des résultats financiers du deuxième trimestre 2024. La conférence est prévue pour le jeudi 8 août 2024, à 8h00 ET. Les investisseurs et les parties intéressées peuvent participer en composant le (888) 210-2654 (États-Unis) ou le (646) 960-0278 (international) avec le code d'accès 7862189. La conférence sera également diffusée en direct sur le site Web de l'entreprise.
Un enregistrement de la conférence sera disponible jusqu'au 7 septembre 2024, et un enregistrement du webinaire sera archivé pendant 90 jours sur le site Web d'Insmed. Cet événement offre aux parties prenantes l'occasion d'obtenir des informations sur les performances financières d'Insmed et de recevoir des mises à jour sur les activités commerciales de l'entreprise.
Insmed Incorporated (Nasdaq: INSM), ein globales biopharmazeutisches Unternehmen, das sich auf seltene Krankheiten konzentriert, hat seine bevorstehende Telefonkonferenz zu den finanziellen Ergebnissen des zweiten Quartals 2024 angekündigt. Die Konferenz ist für Donnerstag, den 8. August 2024, um 8:00 Uhr ET angesetzt. Investoren und Interessierte können teilnehmen, indem sie (888) 210-2654 (USA) oder (646) 960-0278 (international) mit dem Zugangscode 7862189 anrufen. Die Konferenz wird auch live auf der Website des Unternehmens übertragen.
Eine Wiederholung der Telefonkonferenz wird bis zum 7. September 2024 verfügbar sein, und eine Aufzeichnung der Webcast wird 90 Tage lang auf der Website von Insmed archiviert. Diese Veranstaltung bietet Stakeholdern die Möglichkeit, Einblicke in die finanzielle Leistung von Insmed zu gewinnen und Aktualisierungen zu den Geschäftsaktivitäten des Unternehmens zu erhalten.
- None.
- None.
Insmed management will host a conference call for investors beginning at 8:00 a.m. ET on Thursday, August 8, 2024, to discuss the financial results and provide a business update.
Shareholders and other interested parties may participate in the conference call by dialing (888) 210-2654 (
A replay of the conference call will be accessible approximately 1 hour after its completion through September 7, 2024, by dialing (800) 770-2030 (
About Insmed
Insmed Incorporated is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Insmed's first commercial product is a first-in-disease therapy approved in the United States, Europe, and Japan to treat a chronic, debilitating lung disease. The Company is progressing a robust pipeline of investigational therapies targeting areas of serious unmet need, including neutrophil-mediated inflammatory diseases and rare pulmonary disorders. Insmed is also advancing an early-stage research engine encompassing a wide range of technologies and modalities, including artificial intelligence-driven protein engineering, gene therapy, and protein manufacturing. Insmed is headquartered in Bridgewater,
Contact:
Investors:
Bryan Dunn
Executive Director, Investor Relations
Insmed
(646) 812-4030
bryan.dunn@insmed.com
Media:
Mandy Fahey
Vice President, Corporate Communications
Insmed
(732) 718-3621
amanda.fahey@insmed.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/insmed-to-host-second-quarter-2024-financial-results-conference-call-on-thursday-august-8-2024-302207872.html
SOURCE Insmed Incorporated
FAQ
When will Insmed (INSM) release its Q2 2024 financial results?
What time is Insmed's (INSM) Q2 2024 earnings call scheduled for?
How can investors participate in Insmed's (INSM) Q2 2024 earnings call?
Until when will the replay of Insmed's (INSM) Q2 2024 earnings call be available?
